| Matthew Robert Sehring, DO | |
|
3333 N Seminary St, Galesburg, IL 61401-1251 | |
| (309) 344-3161 | |
| Not Available |
| Full Name | Matthew Robert Sehring |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 9 Years |
| Location | 3333 N Seminary St, Galesburg, Illinois |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629458526 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 036144137 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Medical Center | Galesburg, IL | Hospital |
| Osf Saint Lukes Medical Center | Kewanee, IL | Hospital |
| Saint Francis Medical Center | Peoria, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
| Osf Healthcare System | 4284541806 | 75 |
News Archive
Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.
Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.
New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.
Americans overwhelmingly support meaningful medical liability reform and agree that changes to our nation's broken medical liability system should be included in health care reform legislation passed by the Congress, according to a new poll released today by the Health Coalition on Liability and Access.
The United Kingdom is just about to undergo one of the most radical changes of gambling legislation in its history. The new gambling bill will provide the British public with increased opportunities and access to gambling like they have never seen before.
› Verified 3 days ago
| Entity Name | Pekin Prohealth Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932150299 PECOS PAC ID: 1951214576 Enrollment ID: O20031110000647 |
News Archive
Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.
Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.
New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.
Americans overwhelmingly support meaningful medical liability reform and agree that changes to our nation's broken medical liability system should be included in health care reform legislation passed by the Congress, according to a new poll released today by the Health Coalition on Liability and Access.
The United Kingdom is just about to undergo one of the most radical changes of gambling legislation in its history. The new gambling bill will provide the British public with increased opportunities and access to gambling like they have never seen before.
› Verified 3 days ago
| Entity Name | Methodist Medical Center Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982656575 PECOS PAC ID: 1355259714 Enrollment ID: O20031126000494 |
News Archive
Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.
Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.
New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.
Americans overwhelmingly support meaningful medical liability reform and agree that changes to our nation's broken medical liability system should be included in health care reform legislation passed by the Congress, according to a new poll released today by the Health Coalition on Liability and Access.
The United Kingdom is just about to undergo one of the most radical changes of gambling legislation in its history. The new gambling bill will provide the British public with increased opportunities and access to gambling like they have never seen before.
› Verified 3 days ago
| Entity Name | Proctor Health Systems |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134173917 PECOS PAC ID: 3476440173 Enrollment ID: O20040227000906 |
News Archive
Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.
Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.
New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.
Americans overwhelmingly support meaningful medical liability reform and agree that changes to our nation's broken medical liability system should be included in health care reform legislation passed by the Congress, according to a new poll released today by the Health Coalition on Liability and Access.
The United Kingdom is just about to undergo one of the most radical changes of gambling legislation in its history. The new gambling bill will provide the British public with increased opportunities and access to gambling like they have never seen before.
› Verified 3 days ago
| Entity Name | Osf Healthcare System |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1811016124 PECOS PAC ID: 4284541806 Enrollment ID: O20070504000101 |
News Archive
Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.
Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.
New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.
Americans overwhelmingly support meaningful medical liability reform and agree that changes to our nation's broken medical liability system should be included in health care reform legislation passed by the Congress, according to a new poll released today by the Health Coalition on Liability and Access.
The United Kingdom is just about to undergo one of the most radical changes of gambling legislation in its history. The new gambling bill will provide the British public with increased opportunities and access to gambling like they have never seen before.
› Verified 3 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.
Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.
New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.
Americans overwhelmingly support meaningful medical liability reform and agree that changes to our nation's broken medical liability system should be included in health care reform legislation passed by the Congress, according to a new poll released today by the Health Coalition on Liability and Access.
The United Kingdom is just about to undergo one of the most radical changes of gambling legislation in its history. The new gambling bill will provide the British public with increased opportunities and access to gambling like they have never seen before.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Robert Sehring, DO 530 Ne Glen Oak Ave, Peoria, IL 61637-0001 Ph: (309) 655-2730 | Matthew Robert Sehring, DO 3333 N Seminary St, Galesburg, IL 61401-1251 Ph: (309) 344-3161 |
News Archive
Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.
Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.
New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.
Americans overwhelmingly support meaningful medical liability reform and agree that changes to our nation's broken medical liability system should be included in health care reform legislation passed by the Congress, according to a new poll released today by the Health Coalition on Liability and Access.
The United Kingdom is just about to undergo one of the most radical changes of gambling legislation in its history. The new gambling bill will provide the British public with increased opportunities and access to gambling like they have never seen before.
› Verified 3 days ago
Dr. Parthasarathy Srinivasan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 765 N Kellogg St Ste 203, Galesburg, IL 61401 Phone: 309-676-8123 Fax: 309-676-8455 | |
Carl E Strauch, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 834 N Seminary St, 303, Galesburg, IL 61401 Phone: 309-342-9189 | |
Madan L Gupta, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3315 N Seminary St, Galesburg, IL 61401 Phone: 309-344-1000 Fax: 309-344-1054 | |
Mark A Meeker, D. O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3315 N Seminary St, Galesburg, IL 61401 Phone: 309-344-1000 Fax: 309-344-1054 | |
Syed Fahad Imam, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 765 N Kellogg St Ste 203, Galesburg, IL 61401 Phone: 309-676-8123 Fax: 309-676-8455 | |
Dr. Afshin A Khaiser, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3315 N Seminary St, Galesburg, IL 61401 Phone: 309-344-1000 Fax: 309-344-2405 | |
James H King, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3315 N Seminary St, Galesburg, IL 61401 Phone: 309-344-1000 Fax: 309-344-1054 |